The third annual Vanderbilt Alzheimer’s Disease Research Day featured numerous presentations and concluded with a keynote address by Suzanne Craft, PhD, director of the Alzheimer’s Disease Research Center at Wake Forest University.

Vanderbilt researchers report on a new PET imaging probe that will be useful for exploring Alzheimer’s disease pathology.

Vanderbilt researchers have discovered a nanoparticle released from cells, called a “supermere,” which contains enzymes, proteins and RNA associated with multiple cancers, cardiovascular disease, Alzheimer’s disease and even COVID-19.

Vanderbilt researchers took part in an online panel discussion this week sponsored by the Women’s Alzheimer’s Movement (WAM), hosted by journalist and author Maria Shriver, the organization’s founder, and NBC news anchor Richard Lui.

Vanderbilt University Medical Center has received a $31.7 million federal grant to harmonize research data gathered on human subjects in scores of disparate studies of Alzheimer’s disease and related dementias.

A joint project between the Vanderbilt Kennedy Center and the Vanderbilt Center for Cognitive Medicine will help deliver Alzheimer’s disease therapies and treatments to people with Down syndrome (DS).